How could wearable and smartphone tech help people with depression, epilepsy and MS?
RADAR-CNS (Remote assessment of disease and relapse – Central Nervous System), a major new research programme supported by the Innovative Medicines Initiative (IMI) started in April 2016 and will develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.
RADAR-CNS is jointly led by King’s College London and Janssen Pharmaceutica NV, funded by the Innovative Medicines Initiative (a Public Private Partnership established between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union) and includes 24 organisations from across Europe and the US. The programme brings together experts from diverse fields including clinical research, engineering, computer science, information technology, data analytics and health services.[Video source: kingscollegelondon YouTube link]
March 28, 2020
August 05, 2019
June 22, 2019